Status:
UNKNOWN
Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer
Lead Sponsor:
Tongji Hospital
Collaborating Sponsors:
Women's Hospital School Of Medicine Zhejiang University
Conditions:
Endometrial Cancer
Cervical Stromal Invasion
Eligibility:
FEMALE
18+ years
Brief Summary
Retrospectively collect preoperative transvaginal B-mode ultrasound (BMUS), color Doppler flow imaging (CDFI) and three-dimensional ultrasound (3D-US) images and clinical data in patients with non-end...
Detailed Description
Endometrial Cancer is the second most common gynecological cancer in China and the first in Western countries. The common clinical symptom of endometrial cancer is vaginal bleeding, which occurs in ab...
Eligibility Criteria
Inclusion
- Patients diagnosed by operation and pathology
- Patients with preoperative transvaginal ultrasound images
Exclusion
- Past history of gynecological malignant tumors
- Previous pelvic surgery or radiotherapy or chemotherapy
- Poor image quality
- Incomplete pathological or diagnosis report
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05387460
Start Date
October 1 2021
End Date
July 1 2023
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030